Astria Therapeutics (ATXS) Net Income: 2017-2018
Historic Net Income for Astria Therapeutics (ATXS) over the last 2 years, with Dec 2018 value amounting to -$5.9 million.
- Astria Therapeutics' Net Income fell 6.65% to -$5.9 million in Q4 2018 from the same period last year, while for Dec 2018 it was -$26.0 million, marking a year-over-year increase of 5.05%. This contributed to the annual value of -$26.0 million for FY2018, which is 4.93% up from last year.
- Latest data reveals that Astria Therapeutics reported Net Income of -$5.9 million as of Q4 2018, which was down 1.27% from -$5.8 million recorded in Q3 2018.
- Astria Therapeutics' Net Income's 5-year high stood at -$5.5 million during Q4 2017, with a 5-year trough of -$7.9 million in Q1 2017.
- For the 2-year period, Astria Therapeutics' Net Income averaged around -$6.7 million, with its median value being -$6.8 million (2017).
- Data for Astria Therapeutics' Net Income shows a peak YoY increase of 16.70% (in 2018) and a maximum YoY decrease of 6.65% (in 2018) over the last 5 years.
- Over the past 2 years, Astria Therapeutics' Net Income (Quarterly) stood at -$5.5 million in 2017, then decreased by 6.65% to -$5.9 million in 2018.
- Its last three reported values are -$5.9 million in Q4 2018, -$5.8 million for Q3 2018, and -$6.6 million during Q2 2018.